Peter Tobin is a seasoned professional currently serving as the Senior Vice President of Clinical Strategy and Innovation at Telix Pharmaceuticals Limited, a role they began in 2024 after previously holding the position of Vice President of Clinical Strategic Alliances. With a successful career spanning over two decades, they have held significant roles at EMD Serono, Merck Group, Novartis, and Roche, focusing on oncology and immuno-oncology. Peter's expertise includes leading global medical initiatives and product development in solid tumors and targeted therapies. Additionally, they served as a lecturer at the University of Sydney from 2002 to 2005 and earned a degree with high distinction from the same institution.
This person is not in the org chart
This person is not in any teams
This person is not in any offices